Rapamycin (RAPA) or cyclosporine (CsA)
was administered intravenously, daily for 60 days, to
rabbits with heterotopic heart transplants. Groups of 5
rabbits were randomly assigned to receive RAPA at
0.05,O. 1,0.5 or 1 .O mg/kglday or CsA at either 5 .O, 10.0
or 15 mg/kg/day. Dmg vehicle and saline controls were
also included. Animals were examined daily and the
cervical allografts assessed by palpation for
viabilitylrejection. In those animals in which the heart
stopped beating, the heart was removed and processed
for light microscopic evaluation. The duration of the
study was for 60 days at which time the animals were
sacrificed and the transplanted heart and native kidneys
removed and processed for light microscopic assessment
of rejection and drug toxicity respectively. Biochemical
and functional parameters in these animals were
previously reported (Transplantation 5: 340-345, 1993).
Animals that rejected their grafts were maintained on the
dmg until the endpoint of the study to assess toxicity in
the native kidneys. The rejected hearts from these
animals were also harvested for microscopic evaluation.
The results of the study revealed that heart rejection in
drug treated animals was significantly lower than in
corresponding controls but not different among the various drug treated groups. In the kidney, there were no
differences in glomerular tuft area or tuft volume density
amongst drug-treated or control animals. In contrast,
tubule atrophy and interstitial fibrosis were markedl 3 greater in CsA-treated vs RAPA-treated animals (X
5.00, pe0.02). These data suggest that whereas drug
efficacy with respect to heart allograft viability is similar
between CsA and RAPA, renal toxicity is significantly
less in those animals receiving RAPA